您的购物车当前为空
别名 NMNH disodium
β-Nicotinamide mononucleotide, reduced form (NMNH) disodium是β-Nicotinamide mononucleotide的还原形式,具备口服活性。该化合物能够显著提高NAD+和NADH的水平,抑制糖酵解和三羧酸循环以及细胞生长,且其功效依赖于烟酰胺单核苷酸腺苷转移酶 (NMNAT)。

β-Nicotinamide mononucleotide, reduced form (NMNH) disodium是β-Nicotinamide mononucleotide的还原形式,具备口服活性。该化合物能够显著提高NAD+和NADH的水平,抑制糖酵解和三羧酸循环以及细胞生长,且其功效依赖于烟酰胺单核苷酸腺苷转移酶 (NMNAT)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
| 产品描述 | β-Nicotinamide mononucleotide, reduced form (NMNH) disodium is the reduced variant of β-Nicotinamide mononucleotide, with oral bioavailability. This compound significantly increases NAD+ and NADH levels while inhibiting glycolysis, the tricarboxylic acid cycle, and cell growth, mechanisms that are dependent on nicotinamide mononucleotide adenylyltransferase (NMNAT). |
| 体外活性 | β-Nicotinamide mononucleotide, reduced form (100 μM; 12 h) disodium 能显著提高 HepG2 细胞的 NAD + 水平,降低糖酵解及 TCA 循环中间产物的浓度。β-Nicotinamide mononucleotide, reduced form (250-1000 μM; 12-72 h) disodium 则可抑制 HepG2 细胞增殖,并诱导细胞周期停滞。 |
| 体内活性 | 腹腔注射或灌胃给予雄性小鼠单剂量β-Nicotinamide mononucleotide, reduced form (340 mg/kg) disodium,可提高肝脏中的NAD+水平。C57BL/6J小鼠单次腹腔注射β-Nicotinamide mononucleotide, reduced form (250 mg/kg) disodium,能使其肝脏、肾脏、脑、肌肉和全血中的NAD+水平上升2-5倍。 |
| 别名 | NMNH disodium |
| 分子量 | 380.20 |
| 分子式 | C11H15N2Na2O8P |
| CAS No. | 108347-85-9 |
| Smiles | O[C@H]1[C@H](N2C=C(CC=C2)C(N)=O)O[C@@H]([C@H]1O)COP([O-])([O-])=O.[Na+].[Na+] |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
对于不同动物的给药剂量换算,您也可以参考 更多